secwatch.observer — SEC 8-K summary
======================================

Issuer:     CS DIAGNOSTICS CORP. (CSDX)
CIK:        0001106861
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0001683168-24-006898
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CS Diagnostics files 8-K describing business and CS Protect Hydrogel product
----------------------------------------------------------------------------

- Filing provides general overview of CS Diagnostics Corp. as a medical distribution company.
- Highlights CS Protect Hydrogel spacer gel for prostate cancer radiation therapy.
- No specific financial results, contracts, approvals, or material events reported.
- Lists company officers but no changes to leadership are disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106861/000168316824006898/0001683168-24-006898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106861/000168316824006898/csdiag_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-006898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer